Buchwalder A, Krangel M S, Hao P, Diamond D J
Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, CA 91010.
Mol Immunol. 1994 Aug;31(11):857-72. doi: 10.1016/0161-5890(94)90023-x.
We have constructed antigen-specific chimeric human T cell receptor (TCR) molecules deleted of the transmembrane domain and containing the signal sequence for the biosynthesis of the phosphatidyl inositol glycan (GPI) linkage. These membrane-anchored forms of the TCR alpha and beta chains have been expressed in non-T cells, and they are recognized by alpha or beta TCR specific monoclonal antibodies. We have utilized both immunochemical methods and flow cytometry to prove that the enzyme phosphatidylinositol phospholipase C (PI/PLC) is able to cleave the GPI anchored TCR as a heterodimer from the CHO cell surface. We have demonstrated that the alpha/beta TCR heterodimer on the surface of CHO cells will recognize and bind polymers containing fluorescein (FL-polymer), and the binding activity is completely eliminated by the enzyme, PI/PLC. Moreover, soluble forms of the alpha/beta heterodimer will bind tightly to FL substituted sepharose, which demonstrates the retention of biological activity by the TCR after solubilization. Molecular modelling of the putative antigen binding site of the alpha FL beta FL TCR was derived from the known atomic coordinates of eight different hapten or peptide specific antibodies. Mutagenesis of several residues predicted from the model to be important in FL binding gave results consistent with involvement of Ig equivalent CDR2 and CDR3 domains in the antigen binding pocket. Therefore, using a model hapten system in studying recognition of the TCR independent of MHC interactions, we conclude that amino acid residues located in similar positions within CDR domains as compared to the case of MHC restricted TCR recognition are used in the binding of either hapten or peptide antigens.
我们构建了跨膜结构域缺失且含有磷脂酰肌醇聚糖(GPI)连接生物合成信号序列的抗原特异性嵌合人T细胞受体(TCR)分子。这些TCRα链和β链的膜锚定形式已在非T细胞中表达,并可被α或βTCR特异性单克隆抗体识别。我们利用免疫化学方法和流式细胞术证明,磷脂酰肌醇磷脂酶C(PI/PLC)能够从CHO细胞表面将GPI锚定的TCR作为异二聚体切割下来。我们已经证明,CHO细胞表面的α/βTCR异二聚体能够识别并结合含有荧光素的聚合物(FL-聚合物),并且这种结合活性会被PI/PLC酶完全消除。此外,α/β异二聚体的可溶性形式将紧密结合到FL取代的琼脂糖上,这表明TCR在溶解后仍保留生物活性。αFLβFL TCR假定抗原结合位点的分子模型是根据八种不同半抗原或肽特异性抗体的已知原子坐标推导出来的。对模型预测在FL结合中起重要作用的几个残基进行诱变,得到的结果与Ig等效的CDR2和CDR3结构域参与抗原结合口袋一致。因此,在研究独立于MHC相互作用的TCR识别时,使用模型半抗原系统,我们得出结论,与MHC限制性TCR识别情况相比,位于CDR结构域内相似位置的氨基酸残基用于半抗原或肽抗原的结合。